Mark S. Levine, Chief Legal Officer at Immunovant, Inc. (IMVT), sold 8,030 shares at $27.76 ($223K) on 2024-07-24, disclosed to the SEC on 2024-07-26.
Open-market sale of $223k IMVT by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.76 | 4,015 | $111K | 50.0% |
| 2 | $27.76 | 4,015 | $111K | 50.0% |
| Total | $27.76 avg | 8,030 | $223K | 100% |
| Filing → |
| IMVT | SELL | 2024-10-18 | $165K | — | Filing → |
| IMVT | SELL | 2024-08-23 | $206K | — | Filing → |
| IMVT | SELL | 2024-07-19 | $144K | — | Filing → |